Tests a new MRI scan for spinal cord lesions in multiple sclerosis
Tests a new MRI scan to detect spinal cord injury in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research
Key facts
- Where
- Paris, FranceSee the site
Where in France
- Fondation Ophtalmologique Adolphe de Rothschild (FOR)Paris, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondation Ophtalmologique Adolphe de Rothschild
- Trial code
- NCT04906928
- Record updated
- 5 January 2026
- Original description
* verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence. * 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)Read full original descriptionShow less
Evaluation of the Performance of a 3D FGAPSIR Sequence by MRI in the Detection and Characterization of Spinal Cord Injuries in Patients With Multiple Sclerosis
* verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence. * 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)
Inclusion: Patient over 18 years old; To benefit from a medullary exploration planned by 3T MRI as part of a first evaluation or a reassessment of inflammatory involvement of the nevrax; Express consent to participate in the study; Affiliate or beneficiary of a social security scheme.
Exclusion: Patient benefiting from a legal protection measure; Pregnant, parturient or breastfeeding woman; Absolute or relative contraindication to MRI.